Advertisement
Advertisement
U.S. markets open in 9 hours 20 minutes
Advertisement
Advertisement
Advertisement
Advertisement

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.34+0.19 (+2.66%)
At close: 04:00PM EDT
7.34 0.00 (0.00%)
After hours: 04:08PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/29/2022
Current
3/31/202212/31/20219/30/20216/30/20213/31/2021
Market Cap (intraday)
348.90M1.18B1.57B2.16B1.83B1.59B
Enterprise Value
145.15M916.00M1.19B1.72B1.54B1.25B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
7.3724.4046.0663.7348.2512.67
Price/Book (mrq)
0.963.043.935.216.945.68
Enterprise Value/Revenue
3.15119.6859.09202.56157.37167.82
Enterprise Value/EBITDA
-1.59-29.75-80.18-72.30-71.07-62.35

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-81.09%
S&P500 52-Week Change 3-11.60%
52 Week High 351.21
52 Week Low 34.84
50-Day Moving Average 37.29
200-Day Moving Average 326.06

Share Statistics

Avg Vol (3 month) 31.14M
Avg Vol (10 day) 31.19M
Shares Outstanding 548.8M
Implied Shares Outstanding 6N/A
Float 832.81M
% Held by Insiders 111.28%
% Held by Institutions 192.99%
Shares Short (May 30, 2022) 44.3M
Short Ratio (May 30, 2022) 45.53
Short % of Float (May 30, 2022) 49.91%
Short % of Shares Outstanding (May 30, 2022) 48.80%
Shares Short (prior month Apr 28, 2022) 45.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -205.47%
Operating Margin (ttm)-202.10%

Management Effectiveness

Return on Assets (ttm)-13.07%
Return on Equity (ttm)-30.10%

Income Statement

Revenue (ttm)46.01M
Revenue Per Share (ttm)0.97
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)-41.35M
EBITDA -91.65M
Net Income Avi to Common (ttm)-94.54M
Diluted EPS (ttm)-1.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)291.17M
Total Cash Per Share (mrq)5.97
Total Debt (mrq)87.42M
Total Debt/Equity (mrq)23.98
Current Ratio (mrq)6.45
Book Value Per Share (mrq)7.48

Cash Flow Statement

Operating Cash Flow (ttm)-88.63M
Levered Free Cash Flow (ttm)-27.12M
Advertisement
Advertisement